Circulating microRNA-21 as Stable Blood-Based Markers for Patients With ISR After PCI
-
Published:2020-10-14
Issue:6
Volume:23
Page:E756-E762
-
ISSN:1522-6662
-
Container-title:The Heart Surgery Forum
-
language:
-
Short-container-title:HSF
Author:
Zhang Xiong,Xiao Xiao-Ping,Ren Xu- Ai,Xue Wei
Abstract
It recently has been reported that the in-stent restenosis (ISR) of expanded area after percutaneous coronary intervention (PCI) within six months can become a serious postoperative complication. A real-time quantitative PCR was used to analyze the expression of serum miR-21 in 33 ISR and 37 non-ISR patients after PCI. Expression of miR-21 was significantly higher in the ISR group compared with that in the NISR group, and a similar trend also occurred in factor- (TNF-α) level, Interleukin -6 (IL-6) level, and plaque area (PLA). However, a contrary trend occurred in the external elastic membrane area (EEM) and minimal lumen area (MLA). This study suggests that the increased expression of serum miR-21 is related to ISR after PCI, and miR-21 can be a new predictor of ISR.
Publisher
Carden Jennings Publishing Co.
Subject
Cardiology and Cardiovascular Medicine,Surgery,General Medicine